Glen Eagle Advisors’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
Other funds holding DXCM
VCM
VPM
Glen Eagle Advisors's DXCM Position: Q1 2026 in Review
Glen Eagle Advisors held its DexCom (DXCM) position steady in Q1 2026 at 288 shares worth $18.1K. The position accounts for ﹤0.01% of the portfolio, ranked #583.
Glen Eagle Advisors first reported a position in DXCM in Q2 2020 and has held it in 24 quarters since. The position peaked at $53.6K in Q4 2020. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.
- Glen Eagle Advisors held 288 shares of DexCom worth $18.1K as of Q1 2026.
- Glen Eagle Advisors left its DexCom share count unchanged in Q1 2026.
- DexCom made up ﹤0.01% of Glen Eagle Advisors's portfolio in Q1 2026, its #583 holding.
- Glen Eagle Advisors first reported a position in DexCom in Q2 2020 and has held it in 24 quarters since.
- Glen Eagle Advisors's DexCom position peaked at $53.6K in Q4 2020.
- 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.
Based on Glen Eagle Advisors's 13F filing for Q1 2026, filed 15 May 2026.